[PDF][PDF] Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls
…, VMY Lee, M Ono, K Masamoto, H Takano… - Neuron, 2013 - cell.com
Accumulation of intracellular tau fibrils has been the focus of research on the mechanisms
of neurodegeneration in Alzheimer's disease (AD) and related tauopathies. Here, we have …
of neurodegeneration in Alzheimer's disease (AD) and related tauopathies. Here, we have …
[HTML][HTML] Effects of a medium-chain triglyceride-based ketogenic formula on cognitive function in patients with mild-to-moderate Alzheimer's disease
M Ota, J Matsuo, I Ishida, H Takano, Y Yokoi, H Hori… - Neuroscience …, 2019 - Elsevier
Clinical and animal studies suggested that a medium-chain triglyceride (MCT)-based ketogenic
diet provides an alternative energy substrate to the brain and has neuroprotective effects…
diet provides an alternative energy substrate to the brain and has neuroprotective effects…
Differential contributions of prefrontal and hippocampal dopamine D1 and D2 receptors in human cognitive functions
H Takahashi, M Kato, H Takano… - Journal of …, 2008 - Soc Neuroscience
Dopamine D 1 receptors in the prefrontal cortex (PFC) are important for prefrontal functions,
and it is suggested that stimulation of prefrontal D 1 receptors induces an inverted U-shaped …
and it is suggested that stimulation of prefrontal D 1 receptors induces an inverted U-shaped …
PET quantification of tau pathology in human brain with 11C-PBB3
…, H Shimada, Y Ikoma, C Seki, H Takano… - Journal of Nuclear …, 2015 - Soc Nuclear Med
Tau accumulation in the brain is a pathologic hallmark of Alzheimer disease and other
tauopathies. Quantitative visualization of tau pathology in humans can be a powerful method as a …
tauopathies. Quantitative visualization of tau pathology in humans can be a powerful method as a …
[HTML][HTML] Japanese multicenter database of healthy controls for [123I]FP-CIT SPECT
…, M Ogawa, E Imabayashi, N Sato, H Takano… - European journal of …, 2018 - Springer
Purpose The aim of this multicenter trial was to generate a [ 123 I]FP-CIT SPECT database
of healthy controls from the common SPECT systems available in Japan. Methods This study …
of healthy controls from the common SPECT systems available in Japan. Methods This study …
Quantification of dopamine transporter in human brain using PET with 18F-FE-PE2I
…, H Ito, Y Kimura, R Arakawa, H Takano… - Journal of Nuclear …, 2012 - Soc Nuclear Med
18 F-(E)-N-(3-iodoprop-2E-enyl)-2β-carbofluoroethoxy-3β-(4-methylphenyl)nortropane ( 18
F-FE-PE2I) is a new PET radioligand with a high affinity and selectivity for the dopamine …
F-FE-PE2I) is a new PET radioligand with a high affinity and selectivity for the dopamine …
Changes in regional cerebral blood flow during acute electroconvulsive therapy in patients with depression: positron emission tomographic study
H Takano, N Motohashi, T Uema, K Ogawa… - The British Journal of …, 2007 - cambridge.org
BackgroundAlthough electroconvulsive therapy (ECT) is widely used to treat psychiatric
disorders such as depression, its precise neural mechanisms remain unknown.AimsTo …
disorders such as depression, its precise neural mechanisms remain unknown.AimsTo …
Regional dopamine synthesis in patients with schizophrenia using L-[β-11C] DOPA PET
S Nozaki, M Kato, H Takano, H Ito, H Takahashi… - Schizophrenia …, 2009 - Elsevier
The dopamine hypothesis has been the most widely known theory concerning schizophrenia.
However, the exact mechanism including presynaptic dopaminergic activity and its …
However, the exact mechanism including presynaptic dopaminergic activity and its …
Revising polypharmacy to a single antipsychotic regimen for patients with chronic schizophrenia
…, KF Tanaka, K Nomura, H Takano… - International Journal …, 2004 - academic.oup.com
Antipsychotic polypharmacy has been empirically used and a recent trend in favour of that
mode of therapy has been suggested for the treatment of schizophrenia. The clinical efficacy, …
mode of therapy has been suggested for the treatment of schizophrenia. The clinical efficacy, …
Norepinephrine transporter in major depressive disorder: a PET study
S Moriguchi, M Yamada, H Takano… - American Journal of …, 2017 - Am Psychiatric Assoc
Objective: The norepinephrine transporter has been suggested to play a crucial role in major
depressive disorder. However, norepinephrine transporter availability in major depressive …
depressive disorder. However, norepinephrine transporter availability in major depressive …